Our long-term goal is to understand the mechanism(s) by which the hormone melatonin, through activation of its receptors (MT1 and MT2), regulates circadian, visual and neuroendocrine function. The overall goal of this proposal is to identify the molecular determinants and mechanism(s) by which melatonin differentially regulates hMT1 and hMT2 melatonin receptors and affects signal transduction in the mammalian central nervous system. Our hypothesis is that in the native suprachiasmatic nucleus (SCN) physiological concentrations of melatonin rapidly internalize and desensitize the MT2, but not the MT1 melatonin receptor altering the MT2-receptor mediated phase shift o f circadian rhythms. These studies will use state of the art molecular, biochemical and functional measurements in mammalian cells expressing recombinant hMT1 and hMT2 melatonin receptors and in native systems (SCN slice, SCN2.2 cells) to assess the mechanism(s) of melatonin induced receptor desensitization, internalization and cellular trafficking. Specific goals are: a) to identify the molecular determinants of MT1 and MT2 melatonin receptors involved in ligand induced internalization and desensitization and scaffolding proteins necessary for membrane residency; b) to determine homodimer and heterodimer formation in heterologous and native receptor systems; and c) to assess the functional sensitivity of MT2 receptor to mediate phase shift in the rat SCN slice and to stimulate protein kinase C (PKC) in immortalized SCN2.2 cells in culture upon exposure to physiological concentrations of melatonin mimicking the nocturnal surge. Understanding how MT1 and MT2 melatonin receptors are regulated by physiological concentrations of melatonin will increase our understanding of temporally regulated signal transduction events and identify potential targets for drug discovery. Specifically, these studies will shed light into the role of the circadian release of of melatonin in modulating functional responses in native target tissues and will be relevant to understand disturbances of circadian rhythms due to alterations in melatonin production at dusk and dawn. Furthermore, this research will increase our ability to design treatments aimed to alleviate symptoms associate with seasonal affective disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH042922-16
Application #
7211367
Study Section
Special Emphasis Panel (ZRG1-NMB (02))
Program Officer
Desmond, Nancy L
Project Start
1987-07-01
Project End
2009-03-31
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
16
Fiscal Year
2007
Total Cost
$272,389
Indirect Cost
Name
Northwestern University at Chicago
Department
Pharmacology
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Liu, Jiabei; Clough, Shannon J; Hutchinson, Anthony J et al. (2016) MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective. Annu Rev Pharmacol Toxicol 56:361-83
Adamah-Biassi, E B; Zhang, Y; Jung, H et al. (2014) Distribution of MT1 melatonin receptor promoter-driven RFP expression in the brains of BAC C3H/HeN transgenic mice. J Histochem Cytochem 62:70-84
Liu, Jiabei; Somera-Molina, Kathleen C; Hudson, Randall L et al. (2013) Melatonin potentiates running wheel-induced neurogenesis in the dentate gyrus of adult C3H/HeN mice hippocampus. J Pineal Res 54:222-31
Rawashdeh, Oliver; Hudson, Randall L; Stepien, Iwona et al. (2011) Circadian periods of sensitivity for ramelteon on the onset of running-wheel activity and the peak of suprachiasmatic nucleus neuronal firing rhythms in C3H/HeN mice. Chronobiol Int 28:31-8
Dubocovich, Margarita L; Delagrange, Philippe; Krause, Diana N et al. (2010) International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol Rev 62:343-80
Masana, Monica I; Sumaya, Isabel C; Becker-Andre, Michael et al. (2007) Behavioral characterization and modulation of circadian rhythms by light and melatonin in C3H/HeN mice homozygous for the RORbeta knockout. Am J Physiol Regul Integr Comp Physiol 292:R2357-67
Dubocovich, Margarita L (2007) Melatonin receptors: role on sleep and circadian rhythm regulation. Sleep Med 8 Suppl 3:34-42
Dubocovich, Margarita L; Markowska, Magdalena (2005) Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 27:101-10
Masana, Monica I; Soares Jr, Jose M; Dubocovich, Margarita L (2005) 17Beta-estradiol modulates hMT1 melatonin receptor function. Neuroendocrinology 81:87-95
Gerdin, Matthew J; Masana, Monica I; Rivera-Bermudez, Moises A et al. (2004) Melatonin desensitizes endogenous MT2 melatonin receptors in the rat suprachiasmatic nucleus: relevance for defining the periods of sensitivity of the mammalian circadian clock to melatonin. FASEB J 18:1646-56

Showing the most recent 10 out of 53 publications